Dysregulation of NF-κB promotes tumor growth, survival, and resistance to therapy by upregulating anti-apoptotic genes such as Bcl-2, Bcl-xL, and XIAP, thereby inhibiting apoptosis 21-25. Here, BCL2L1 is linked to neoplasm.